PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer.
Journal
Applied clinical informatics
ISSN: 1869-0327
Titre abrégé: Appl Clin Inform
Pays: Germany
ID NLM: 101537732
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
entrez:
19
1
2022
pubmed:
20
1
2022
medline:
24
3
2022
Statut:
ppublish
Résumé
Prostate cancer (PCa) is a severe public health issue and the most common cancer worldwide in men. Early diagnosis can lead to early treatment and long-term survival. The addition of the multiparametric magnetic resonance imaging in combination with ultrasound (mpMRI-U/S fusion) biopsy to the existing diagnostic tools improved prostate cancer detection. Use of both tools gradually increases in every day urological practice. Furthermore, advances in the area of information technology and artificial intelligence have led to the development of software platforms able to support clinical diagnosis and decision-making using patient data from personalized medicine. We investigated the current aspects of implementation, architecture, and design of a health care information system able to handle and store a large number of clinical examination data along with medical images, and produce a risk calculator in a seamless and secure manner complying with data security/accuracy and personal data protection directives and standards simultaneously. Furthermore, we took into account interoperability support and connectivity to legacy and other information management systems. The platform was implemented using open source, modern frameworks, and development tools. The application showed that software platforms supporting patient follow-up monitoring can be effective, productive, and of extreme value, while at the same time, aiding toward the betterment medicine clinical workflows. Furthermore, it removes access barriers and restrictions to specialized care, especially for rural areas, providing the exchange of medical images and patient data, among hospitals and physicians. This platform handles data to estimate the risk of prostate cancer detection using current state-of-the-art in eHealth systems and services while fusing emerging multidisciplinary and intersectoral approaches. This work offers the research community an open architecture framework that encourages the broader adoption of more robust and comprehensive systems in standard clinical practice.
Sections du résumé
BACKGROUND AND OBJECTIVE
Prostate cancer (PCa) is a severe public health issue and the most common cancer worldwide in men. Early diagnosis can lead to early treatment and long-term survival. The addition of the multiparametric magnetic resonance imaging in combination with ultrasound (mpMRI-U/S fusion) biopsy to the existing diagnostic tools improved prostate cancer detection. Use of both tools gradually increases in every day urological practice. Furthermore, advances in the area of information technology and artificial intelligence have led to the development of software platforms able to support clinical diagnosis and decision-making using patient data from personalized medicine.
METHODS
We investigated the current aspects of implementation, architecture, and design of a health care information system able to handle and store a large number of clinical examination data along with medical images, and produce a risk calculator in a seamless and secure manner complying with data security/accuracy and personal data protection directives and standards simultaneously. Furthermore, we took into account interoperability support and connectivity to legacy and other information management systems. The platform was implemented using open source, modern frameworks, and development tools.
RESULTS
The application showed that software platforms supporting patient follow-up monitoring can be effective, productive, and of extreme value, while at the same time, aiding toward the betterment medicine clinical workflows. Furthermore, it removes access barriers and restrictions to specialized care, especially for rural areas, providing the exchange of medical images and patient data, among hospitals and physicians.
CONCLUSION
This platform handles data to estimate the risk of prostate cancer detection using current state-of-the-art in eHealth systems and services while fusing emerging multidisciplinary and intersectoral approaches. This work offers the research community an open architecture framework that encourages the broader adoption of more robust and comprehensive systems in standard clinical practice.
Identifiants
pubmed: 35045583
doi: 10.1055/s-0041-1741481
pmc: PMC8769808
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
91-99Informations de copyright
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Déclaration de conflit d'intérêts
None declared.
Références
Urol Oncol. 2017 Jan;35(1):30.e9-30.e15
pubmed: 27663393
Cancer Inform. 2011;10:217-26
pubmed: 21918596
CA Cancer J Clin. 2016 Jul;66(4):326-36
pubmed: 26594835
Curr Opin Urol. 2013 Jan;23(1):43-50
pubmed: 23138468
Semin Roentgenol. 2003 Jul;38(3):270-81
pubmed: 14513730
Int J Med Inform. 2007 Dec;76 Suppl 3:S425-32
pubmed: 17604684
Cancer Inform. 2011 Mar 23;10:83-91
pubmed: 21552494
Eur Urol. 2015 Apr;67(4):627-36
pubmed: 25511988
Health Technol Assess. 2013 May;17(20):vii-xix, 1-281
pubmed: 23697373
World J Urol. 2021 Feb;39(2):407-413
pubmed: 32335733
J Magn Reson Imaging. 2013 May;37(5):1035-54
pubmed: 23606141
BMC Med Inform Decis Mak. 2011 Mar 08;11:16
pubmed: 21385459
Mo Med. 2018 Mar-Apr;115(2):151-155
pubmed: 30228708
Lancet. 2017 Feb 25;389(10071):815-822
pubmed: 28110982
Urology. 2007 Dec;70(6):1117-20
pubmed: 18158030
J Urol. 2015 Apr;193(4):1178-84
pubmed: 25444971
Med Clin North Am. 2018 Mar;102(2):199-214
pubmed: 29406053
Eur Urol. 2015 Dec;68(6):1045-53
pubmed: 25656808
Appl Clin Inform. 2021 Jan;12(1):17-26
pubmed: 33440429
Open Med Inform J. 2012;6:1-8
pubmed: 22505956
J Digit Imaging. 2004 Sep;17(3):205-16
pubmed: 15534753
Br J Radiol. 2012 Nov;85 Spec No 1:S3-17
pubmed: 22844031
Brachytherapy. 2017 Nov - Dec;16(6):1106-1112
pubmed: 28807747
Curr Opin Urol. 2015 Nov;25(6):536-42
pubmed: 26383038
Appl Clin Inform. 2020 Mar;11(2):200-209
pubmed: 32187632
Int J Med Inform. 2013 Oct;82(10):973-9
pubmed: 23850383
JAMA. 2017 Jun 27;317(24):2532-2542
pubmed: 28655021
J Am Med Inform Assoc. 2014 Oct;21(e2):e363-8
pubmed: 24748607
J Am Med Inform Assoc. 1997 May-Jun;4(3):199-212
pubmed: 9147339
JAMA. 2015 Jan 27;313(4):390-7
pubmed: 25626035
Appl Clin Inform. 2021 Mar;12(2):245-250
pubmed: 33763846
Cancers (Basel). 2020 Apr 22;12(4):
pubmed: 32331449
Appl Clin Inform. 2020 May;11(3):399-404
pubmed: 32492716
Eur Radiol. 2002 Apr;12(4):920-7
pubmed: 11960249
BMJ. 2006 May 6;332(7549):1089-92
pubmed: 16675820
J Digit Imaging. 2007 Nov;20 Suppl 1:125-9
pubmed: 17917780